Structure of a type II thymidine kinase with bound dTTP

被引:48
作者
Birringer, MS
Claus, MT
Folkers, G
Kloer, DP
Schulz, GE
Scapozza, L
机构
[1] ETH, Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland
[2] Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany
关键词
human thymidine kinase; antiviral drugs; dTTP; cancer; suicide gene; zinc finger;
D O I
10.1016/j.febslet.2005.01.034
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The structure of human cytosolic thymidine kinase in complex with its feedback inhibitor 2'-deoxythymidine-5'-triphosphate was determined. This structure is the first representative of the type 11 thymidine kinases found in several pathogens. The structure deviates strongly from the known structures of type I thymidine kinases such as the Herpes simplex enzyme. It contains a zinc-binding domain with four cysteines complexing a structural zinc ion. Interestingly, the backbone atoms of the type 11 enzyme bind thymine via hydrogen-bonds, in contrast to type 1, where side chains are involved. This results in a specificity difference exploited for antiviral therapy. The presented structure will foster the development of new drugs and prodrugs for numerous therapeutic applications. (C) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1376 / 1382
页数:7
相关论文
共 36 条
  • [1] HIGH-RESOLUTION STRUCTURES OF ADENYLATE KINASE FROM YEAST LIGATED WITH INHIBITOR AP(5)A, SHOWING THE PATHWAY OF PHOSPHORYL TRANSFER
    ABELE, U
    SCHULZ, GE
    [J]. PROTEIN SCIENCE, 1995, 4 (07) : 1262 - 1271
  • [2] MAMMALIAN DEOXYRIBONUCLEOSIDE KINASES
    ARNER, ESJ
    ERIKSSON, S
    [J]. PHARMACOLOGY & THERAPEUTICS, 1995, 67 (02) : 155 - 186
  • [3] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [4] Structure to 1.9 Å resolution of a complex with herpes simplex virus type-1 thymidine kinase of a novel, non-substrate inhibitor:: X-ray crystallographic comparison with binding of aciclovir
    Bennett, MS
    Wien, F
    Champness, JN
    Batuwangala, T
    Rutherford, T
    Summers, WC
    Sun, HM
    Wright, G
    Sanderson, MR
    [J]. FEBS LETTERS, 1999, 443 (02) : 121 - 125
  • [5] HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia
    Bonini, C
    Ferrari, G
    Verzeletti, S
    Servida, P
    Zappone, E
    Ruggieri, L
    Ponzoni, M
    Rossini, S
    Mavilio, F
    Traversari, C
    Bordignon, C
    [J]. SCIENCE, 1997, 276 (5319) : 1719 - 1724
  • [6] BRUGNER AT, 1998, ACTA CRYSTALLOGR D, V54, P905
  • [7] Cobben DCP, 2003, J NUCL MED, V44, P1927
  • [8] Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods
    delaFortelle, E
    Bricogne, G
    [J]. MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 : 472 - 494
  • [9] SELECTIVITY OF ACTION OF AN ANTI-HERPETIC AGENT, 9-(2-HYDROXYETHOXYMETHYL)GUANINE
    ELION, GB
    FURMAN, PA
    FYFE, JA
    DEMIRANDA, P
    BEAUCHAMP, L
    SCHAEFFER, HJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (12) : 5716 - 5720
  • [10] Structure and function of cellular deoxyribonucleoside kinases
    Eriksson, S
    Munch-Petersen, B
    Johansson, K
    Eklund, H
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (08) : 1327 - 1346